Indotecan (LMP400) and AM13-55: Two Novel Indenoisoquinolines Show Potential for Treating Visceral Leishmaniasis

Effect of topoisomerase inhibitors and DNA-binding drugs on the cell proliferation and ultrastructure of Trypanosoma cruzi

(2011) Aline Araujo Zuma et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

7-Azaindenoisoquinolines as Topoisomerase I Inhibitors and Potential Anticancer Agents

(2011) Evgeny Kiselev et al.   JOURNAL OF MEDICINAL CHEMISTRY

Leishmania antimony resistance: what we know what we can learn from the field

(2011) Khatima Aït-Oudhia et al.   PARASITOLOGY RESEARCH

Identification of Small Molecule Lead Compounds for Visceral Leishmaniasis Using a Novel Ex Vivo Splenic Explant Model System

(2011) Yaneth Osorio et al.   PLoS Neglected Tropical Diseases

Mammalian Expression of Infrared Fluorescent Proteins Engineered from a Bacterial Phytochrome

(2009) X. Shu et al.   SCIENCE

Activity of Indenoisoquinolines against African Trypanosomes

(2008) R. P. Bakshi et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Mutational study of the “catalytic tetrad” of DNA topoisomerase IB from the hemoflagellate Leishmania donovani: Role of Asp-353 and Asn-221 in camptothecin resistance

(2008) Rosario Diaz-González et al.   BIOCHEMICAL PHARMACOLOGY

Gene disruption of the DNA topoisomerase IB small subunit induces a non-viable phenotype in the hemoflagellate Leishmania major

(2008) Rafael Balaña-Fouce et al.   BMC MICROBIOLOGY

Canine leishmaniosis – new concepts and insights on an expanding zoonosis: part two

(2008) Guadalupe Miró et al.   TRENDS IN PARASITOLOGY

Next generation topoisomerase I inhibitors: Rationale and biomarker strategies

(2007) Beverly A. Teicher   BIOCHEMICAL PHARMACOLOGY